Connor, Clark & Lunn Investment Management Ltd. - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$28,497
-91.6%
15,404
-89.4%
0.00%
-100.0%
Q3 2022$339,000
-11.3%
144,885
+14.9%
0.00%0.0%
Q2 2022$382,000
-67.1%
126,073
-26.3%
0.00%
-66.7%
Q1 2022$1,162,000
-20.4%
171,124
-2.1%
0.01%
-14.3%
Q4 2021$1,459,000
+62.5%
174,738
+44.5%
0.01%
+40.0%
Q3 2021$898,000
+81.8%
120,898
+66.5%
0.01%
+66.7%
Q2 2021$494,000
-43.5%
72,596
-14.8%
0.00%
-40.0%
Q1 2021$875,000
+31.6%
85,195
-10.3%
0.01%
+25.0%
Q4 2020$665,000
-18.8%
94,929
-5.4%
0.00%
-20.0%
Q3 2020$819,000
-33.9%
100,386
-44.1%
0.01%
-44.4%
Q2 2020$1,239,000
+41.8%
179,564
-2.5%
0.01%
+12.5%
Q1 2020$874,000
-46.3%
184,088
-1.3%
0.01%
-27.3%
Q4 2019$1,628,000
+159.6%
186,488
-0.9%
0.01%
+175.0%
Q3 2019$627,000
-28.1%
188,188
+6.8%
0.00%
-33.3%
Q2 2019$872,000
-23.6%
176,138
-4.4%
0.01%
-25.0%
Q1 2019$1,142,000
+101.4%
184,238
+9.5%
0.01%
+100.0%
Q4 2018$567,000
-32.7%
168,310
+29.9%
0.00%
-20.0%
Q3 2018$842,000
+45.4%
129,530
+71.4%
0.01%
+66.7%
Q2 2018$579,00075,5750.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 10,230,349$63,428,00041.36%
TRV GP III, LLC 3,048,780$18,902,0009.26%
Omega Fund Management, LLC 1,059,930$6,572,0001.39%
Alambic Investment Management, L.P. 50,622$314,0000.13%
Spark Investment Management LLC 244,300$1,514,0000.07%
ALGERT GLOBAL LLC 14,182$88,0000.05%
Redmile Group, LLC 254,590$1,578,0000.05%
Granahan Investment Management 125,533$778,0000.04%
GSA CAPITAL PARTNERS LLP 38,602$239,0000.02%
Frontier Wealth Management LLC 27,099$168,0000.02%
View complete list of JOUNCE THERAPEUTICS INC shareholders